Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

NCT06717464 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Gallbladder Cancer
Hilar Cholangiocarcinoma
Distal Cholangiocarcinoma

Interventions

DRUG: Capecitabine
DRUG: Toripalimab

Sponsor

Tianjin Medical University Cancer Institute and Hospital